PeptideInfo.ca is an independent educational publication for Canadian readers. We explain peptide science, evidence, safety, and regulation in plain language – with primary sources close at hand.
Why this publication exists
Interest in peptides has grown faster than the quality of public information about them. Online discussions often blur important boundaries: a molecule versus a finished product, a laboratory finding versus human evidence, or an authorized medicine versus an unauthorized injectable sold through a website.
Our job is to make those boundaries visible. We ask three questions repeatedly: What is the evidence? What is the exact Canadian regulatory status? What remains unknown?
Our independence
PeptideInfo.ca is not a clinic, pharmacy, healthcare provider, product seller, or government service. At launch, we carry no product advertising and accept no affiliate commission, referral fee, or sponsorship from peptide vendors, pharmacies, clinics, telehealth providers, compounders, or manufacturers.
If that funding model ever changes, the relationship will be disclosed clearly and our editorial standards will be reviewed before the change. A future clinical business, if one is ever lawful and appropriate, would require separate legal, clinical, editorial, and privacy governance.
Who prepares the content
Launch articles are prepared by the PeptideInfo Editorial Desk from cited public sources. They have undergone a source check, not a clinical review. We do not display physician, pharmacist, or scientist credentials unless a real, named professional has personally reviewed the work and agreed to be identified.
Drafting and editing tools, including artificial intelligence, may assist with organization or language. They do not replace source verification or expert review. Each article states its review level and the date its Canadian status was checked.
What comes next
Our priorities are deeper evidence profiles, regular Canadian regulatory updates, French versions of cornerstone resources, and named subject-matter review. Reader trust matters more than publishing volume.